-
April 28, 2026
Battery-maker Duracell cannot escape chemical company BASF Corp.'s lawsuit accusing it of stealing trade secrets about its lithium battery technology after gaining access to the information through a cooperation agreement, a Delaware federal judge ruled Tuesday.
-
April 28, 2026
A Delaware bankruptcy judge on Tuesday allowed bankrupt home lending broker Impac Mortgage to continue to control the sale of its stock after hearing that millions of dollars in transactions took place despite an emergency order he entered Monday to restrict trading.
-
April 28, 2026
A group of Uber Black drivers and the ride-hailing company agreed Tuesday to dismiss the drivers' appeal before the Third Circuit in a protracted worker classification dispute that has spanned a decade, according to a federal court filing.
-
April 28, 2026
A Korean semiconductor company specializing in memory chips clashed with a former executive in Delaware Chancery Court on Tuesday over whether a $2.36 million stock buyback stripped him of the right to sue before he filed a records request action.
-
April 28, 2026
A Delaware judge Tuesday agreed to convert the bankruptcy of charity financial technology group Flipcause to a Chapter 7 liquidation after its Chapter 11 trustee sold its assets and reached a settlement with creditors.
-
April 28, 2026
Hikma Pharmaceuticals PLC and Cipla Ltd. have reached settlements with Pfizer Inc. in a case over the two defendants' efforts to create generic versions of the heart medication Vyndamax.
-
April 28, 2026
When the U.S. Supreme Court hears arguments Wednesday in a patent case involving "skinny labels" on generic drugs, a longtime patent attorney as well as a government attorney who often handles intellectual property cases will face an appellate specialist who has argued many high court cases.
-
April 28, 2026
A New Jersey man convicted of making $40 million from filing false tax returns in a countrywide securities scheme asked the Third Circuit to reconsider affirming his conviction, citing what he described as a conflict of interest and a misreading of arguments in the ruling against him.
-
April 28, 2026
A medical aesthetics technology company has sued a Korean buyer in the Delaware Chancery Court, accusing it of backing out of a $20 million deal to purchase a hair restoration business after attempting to slash the price at the last minute.
-
April 27, 2026
After a run of litigation losses, Meta Platforms Inc. will have to rethink its strategy in and out of court in an effort to beat back suits from coast to coast claiming that it is illegally hooking kids on Instagram, experts said, with everything from aggressive litigation to a global settlement on the table.
-
April 27, 2026
The governments of four Canadian provinces have urged the Ninth Circuit to reject an appeal from junior hockey players accusing the National Hockey League and its developmental organizations of suppressing compensation.
-
April 27, 2026
A Delaware Chancery Court hearing Monday laid bare a procedural fight over whether a Trump-linked SPAC must immediately pay disputed legal fees to its former CEO or can withhold them while seeking review of a magistrate's ruling.
-
April 27, 2026
BioNTech subsidiary CureVac has launched a new patent infringement suit against Moderna, claiming its COVID-19 vaccine infringed a handful of patents, saying the Massachusetts-based company "exploited" its messenger RNA technology.
-
April 27, 2026
Wren US Holdings Inc., a kitchen design firm based in the northeastern United States, has filed for Chapter 7 liquidation in Delaware, citing between $100 million and $500 million each of assets and liabilities.
-
April 27, 2026
The Third Circuit on Monday upheld its decision that Whittaker Clark & Daniels was authorized to file for Chapter 11 and certain claims against the defunct talc supplier's corporate successor belong to the debtor, not personal injury claimants.
-
April 27, 2026
The Delaware Chancery Court this past week tackled a fresh mix of deal litigation, procedural disputes and fiduciary duty claims, with several rulings and filings underscoring the court's continued focus on contractual precision, forum enforcement and the limits of stockholder challenges.
-
April 24, 2026
The U.S. Supreme Court will close out its oral argument portion of the 2025 October term by hearing a panoply of disputes over the constitutionality of geofence warrants, the existence of aiding and abetting torture claims, and the rescission of temporary protected status for hundreds of thousands of immigrants.
-
April 24, 2026
Natera asked the U.S. Supreme Court to reject a petition from rival CareDx asking it to review a Third Circuit decision that erased a $45 million jury verdict stemming from CareDx's false advertising claims, saying Friday the circuit split that CareDx claims exists is "imagined."
-
April 24, 2026
A coalition of Democrat-led states is asking a Massachusetts federal judge to permanently block core provisions of President Donald Trump's executive order limiting mail-in voting, arguing the directive unlawfully encroaches on states' authority over elections and violates the Constitution's separation of powers.
-
April 24, 2026
The launch of the refund process for tariffs struck down by the U.S. Supreme Court marks the start of lengthy and multifaceted court battles as companies fight with consumers — and amongst themselves — about who gets a slice of the $166 billion pie, experts told Law360.
-
April 24, 2026
A GPGI Inc. investor has filed suit in Delaware seeking to challenge the company's planned move to Nevada, saying the reincorporation — part of a wider trend of companies weighing exits from Delaware — would benefit insiders while limiting stockholders' ability to pursue claims tied to earlier transactions.
-
April 24, 2026
Danaher Corp. executives are facing a proposed securities class action in Delaware federal court alleging they profited while misleading stockholders about the slowing sales of its diagnostics and bioprocessing products.
-
April 24, 2026
Pfizer and Israeli generic-drug maker Dexcel on Friday agreed to drop a case Pfizer brought to block Dexcel from creating a generic version of the heart medication Vyndamax.
-
April 24, 2026
AnaptysBio and Tesaro, alongside Tesaro parent GlaxoSmithKline LLC, sparred Friday in the Delaware Chancery Court over the scope of discovery in the biotechnology firms' contract fight regarding cancer drug Jemperli, with each side accusing the other of trying to tilt the evidentiary record ahead of a fast-approaching trial in July.
-
April 23, 2026
A group of 12 Republican-led states have asked a Massachusetts federal judge to let them intervene as defendants in 23 Democratic-led states' lawsuit over President Donald Trump's March 31 executive order placing limits on mail-in voting.